<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-20T23:17:22Z</responseDate><request verb="GetRecord" identifier="oai:wakespace.lib.wfu.edu:10339/30393" metadataPrefix="dim">https://wakespace.lib.wfu.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:null:10339/30393</identifier><datestamp>2026-09-18T11:50:42Z</datestamp><setSpec>com_10339_14934</setSpec><setSpec>col_10339_38132</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Barner, Dionne Doshia</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2011-02-16T21:42:12Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2011-12-16T09:30:12Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2010</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://wakespace.lib.wfu.edu/handle/10339/30393</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">The increased numbers of clinical trials taking place developing countries have raised issues concerning the researcher&amp;apos;s obligation to trial participants, the host community, or the host country at the conclusion of a clinical trial. One of the most controversial obligations is the provision of posttrial access after a clinical research trial. This thesis summarizes the principles and guidelines that suggest or require the inclusion of a posttrial access framework at the conclusion of a clinical research trial in the specific context of HIV antiretroviral clinical trials conducted in developing countries, and determines whether the National Institutes of Health&amp;apos;s existing posttrial access provision adequately addresses the issues related to mandating posttrial access.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en_US">Wake Forest University</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">AIDS</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Antiretroviral Treatment</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Clinical Trial</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">HIV</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">National Institutes of Health</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Research</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">POSTTRIAL CLINICAL ACCESS: AN EXAMINATION OF THE PRINCIPLES AND GUIDELINES SUPPORTING THE POSTTRIAL ACCESS FRAMEWORK AND A DETERMINATION OF WHETHER THE UNITED STATES CAN DEVELOP A GUIDANCE MANDATING THE PROVISION OF POSTTRIAL ACCESS</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeChair" lang="en_US">King, Nancy M.</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Iltis, Ana</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline" lang="en_US">Bioethics</dim:field>
   <dim:field mdschema="thesis" element="embargo" qualifier="terms" lang="en_US">2011-12-16</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>